Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles
Ulrika Carlander,1 Dingsheng Li,2 Olivier Jolliet,2 Claude Emond,3,4 Gunnar Johanson1 1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 2Department of Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, MI, USA; 3BioSimulation Con...
Guardado en:
Autores principales: | Carlander U, Li D, Jolliet O, Emond C, Johanson G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6bb7ab44c7b140ed82c0f8feccbb7593 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development
por: Cvijić Sandra, et al.
Publicado: (2021) -
Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug–Drug and Drug–Disease Interactions of Apatinib
por: Hongrui Liu, et al.
Publicado: (2021) -
Pharmacokinetic evaluation of D-ribose after oral and intravenous administration to healthy rabbits
por: Alzoubi KH, et al.
Publicado: (2018) -
Ethosome-Derived Invasomes as a Potential Transdermal Delivery System for Vardenafil Hydrochloride: Development, Optimization and Application of Physiologically Based Pharmacokinetic Modeling in Adults and Geriatrics
por: Ammar HO, et al.
Publicado: (2020) -
Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
por: Roganović Maša, et al.
Publicado: (2021)